Watch Demo

Hungary Lipid Modifying Drug Industry Outlook 2022 - 2026

See how Hungary Lipid Modifying Drug performed compared to key markets such as South Korea, Spain and Italy.

Key Market Indicators

Hungarian lipid modifying medicine sales are set to reach $44 million by 2026. In 2021, sales hit $61 million, down 5% from the previous year. Since 2008, sales have dropped 1.9% annually. Hungary placed thirteenth in the ranking, behind the Czech Republic at $61 million. Spain, Italy, and Germany followed in second, third, and fourth place, respectively.

Marketing Banner

Hungary Lipid Modifying Drug Market Data and Forecasts

How much will Hungary Lipid Modifying Drug Market grow to 2026?

Forecast: Lipid Modifying Medicine Sales in Hungary
Forecast: Lipid Modifying Medicine Sales in Hungary
Forecast: Lipid Modifying Medicine Sales in Hungary
Forecast: Lipid Modifying Medicine Use in Hungary
Forecast: Lipid Modifying Medicine Sales in Hungary
More in Lipid Modifying Drug Industry for 2028